Two sorts of herpetic infections affect the corneal stroma, namely those due to herpes simplex and those due to herpes zoster infection. Both conditions present peculiar and testing diagnostic or therapeutic problems in many cases, and both conditions are often difficult to treat, prone to recurrences leading to corneal scarring, progression of disease to other parts of the eye not initially affected, and much visual loss. It is uncertain whether stromal disease is caused by viral replication alone (leading to cytolysis), by virally induced immunological mechanisms, or a combination of both, and this uncertainty is reflected in the inadequacy of treatment of these conditions. Traditionally both conditions have been treated with steroids, but treatment has been prolonged, with frequent recurrences, and it is sometimes difficult to wean a patient completely off low dose maintenance topical steroids. Often despite treatment the disease spreads to parts of the eye not initially affected.' Furthermore steroids, apart from being associated with local side effects, can lead to a continuation of the disease process by enhancing viral replication and suppressing local immune and defence mechanisms, and this could explain the chronicity of the disease.
The aim of this paper will be to present evidence that viral replication plays a major part in the disease process, and that early antiviral drug treatment of these two conditions has many advantages and is possible without the concomitant use of steroids.
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Herpes simplex stromal disease
Herpes simplex virus infection is common throughout the world and in the United Kingdom represents the commonest infectious cause of blindness, with 2-3% of all cases being notified to the central register.2 Stromal disease occurs in 25% of patients after their first herpes simplex epithelial ulcer,34 with 75% occurring within the first year. If topical steroids are used in the initial ulcerative attack, there is a higher incidence of stromal disease. 35 There are two sorts of stromal response, that underlying an active epithelial ulcer, 4nd that occurring some time after the epithelial lesion has healed, or indeed occurring without a preceding epithelial lesion. In the latter case the typical stromal lesion of disciform keratitis is a centrally localised infiltration with oedema and swelling of the corneal stroma, folds in Descemet's membrane, and sometimes secondary glaucoma, uveitis, or occasionally an overlying dendritic ulcer. Such humoral and cellular mediated responses would block viral replication, causing an abortive reaction, but as the virus has already entered the keratocyte its surface antigenicity would have been altered, so that the corneal defence mechanism would recognise it as 'non-self', producing a cell mediated response. It is a feature of both herpes simplex and zoster disciform keratitis that the disease process is chronic. If the reaction was simply due to a cell mediated hypersensitivity reaction, it would be expected to be self limiting, but with topical steroid treatment, either after or during withdrawal, rebound recurrences are frequent, suggesting continued antigenic stimulus. Nowadays, very few cases of herpes simplex stromal disease are left untreated with steroids, and much of the severity of these cases has been attributed to the advent of steroids,'0 which lead to local immunosuppression but allow viral replication to proceed with continued antigenic stimulation.
But what is the evidence that viral replication plays a part in the stromal response? In herpes simplex keratitis, tear herpes simplex virus (HSV) specific secretary IgA (sIgA) has been found after acute epithelial disease," and there is a marked local production of virus specific IgG subclass in response to epithelial and stromal inlection.9 Antibody in this subclass may be poorly neutralising, as it fails to fix complement and only weakly promotes an antibodydependent cell mediated cytotoxic reaction. Moreover IgG4 antibody production may result in an atopic reaction, as it combines with mast cells and causes degranulation when cross-linked by antigens, and this would account for some of the stromal destruction and response seen in stromal disease.
It was Barrie Jones who with Alan Patterson" showed that, if disciform keratitis was treated alone with steroids, a herpes simplex ulcer would appear on the epithelium in a high percentage of such cases. Herpes simplex particles have been demonstrated in the corneal stroma"'7 and HSV isolated from organ cultured corneal discs in patients with disciform keratitis. 118 Herpes simplex viral particles have been seen in necrotising stromal keratitis."'9 Some workers have attributed disciform keratitis to a direct viral invasion of the endothelium on the basis of herpes simplex virus isolation from the aqueous,'
and herpes simplex viral has been cultured from the aqueous in cases of focal iritis and persistent endotheliitis with a secondary glaucoma.20 Incomplete virus, virions, or empty capsids have been found in the stroma of a patient with disciform keratitis, with HSV antigen localised either near herpes virions in keratocyte cell nuclei or in the stroma in areas of degenerating keratocytes'1'8 and on keratocyte nuclear membranes. 16 The sources of such virus include the stroma itself, the ocular adnexa and tears, and the trigeminal ganglion known to be colonised after infection21 reaching the stroma by way of the corneal branchesthe so-called back door approach22. Such continued antigenic stimulation would suggest initiation by residual virus or viral remnants. The clinical appearance of disciform keratitis can be produced in the rabbit eye by herpes antigen injection,124 antigen being found on the stromal keratocytes with lymphocytes in close proximity, suggesting a cell mediated response. The direct injection of herpes virus into the rabbit stroma produces infiltrates, though its similarity to the clinical picture of disciform keratitis is uncertain, and such an animal model is probably more akin to the infiltrate beneath an ulcer in man. Antiviral treatment of these infiltrates with either triflurothymidine& or bromovinyldeoxyuridine26 improved the stromal response.
In rabbits different herpes simplex strains produce different responses. Strains producing a stromal response have an increased glycoprotein content compared with those producing only epithelial responses,27 and there is evidence that genetics plays a part, for the viral genome determines the extent of ocular herpes infection, its severity, its tendency towards recurrent disease, and the tissue response to steroids, independently of any host immunity or resistance.8 If the appropriate HSV strain is inoculated into the rabbit cornea, stromal involvement is seen beneath the ulcer, and a disciform keratitis lesion is seen after the seventh day.281 But polymorphonuclear cells are important in the development of the lesion, for if the rabbits are treated with serum acting against the polymorphonuclear cells the reaction is much less.0
In herpes zoster infection the exact mechanism and pathogenesis of the ocular signs is not known, partly because of the paucity of pathology of the stromal lesions and partly owing to the lack of a suitable animal model. Herpes zoster virus has been cultured from the acute epithelial lesions of both punctate keratopathy and pseudodendrites," from which multinuclear giant cells and intranuclear occlusion have been found32 and which are the most common manifestation of ocular involvement. A high proportion (92%) of the anterior stromal deposits which resolve into nummular scars occur in areas underlying a previous punctate keratopathy or pseudodendritic ulcer6 (Table 1) . These lesions could be due to direct viral invasion, or the diffusion of soluble viral antigen into the stroma, or damage to the terminal corneal nerves from virus travelling down the trigeminal branch. Similarly keratouveitis frequently occurs after epithelial involvement-in 95% of patients6 (Table 1) . It is uncertain whether the ocular abnormalities are due to vasculitis causing ischaemia or chronic inflammation. Histological examination of early cases has shown that only the epithelium tends to be affected, with the deep corneal layers clear, but in chronically affected cases granulomatous reactions to Descemet's membrane have been seen,3" and viral particles have been found in the endothelium'43 and retina.?6 Disciform keratitis also occurs after epithelial disease but not in the same area, and, as lymphocytes are found in the affected region, it is thought to be due to a hypersensitivity reaction to viral antigen. 6 Thus the available evidence points to direct viral involvement of the stromal lesions in both herpes simplex and zoster disease, either by setting up a cytotoxic reaction after cellular invasion, or by initiating immunological mechanisms which are responsible for the clinical signs that are so familiar in these cases. If it could be shown that those antiviral agents which enter the stroma in therapeutic concentrations do control the disease process, this would be evidence that viral replication at least plays a partan initiating role-in such disease processes.
Clinical results

TOPICAL ANTIVIRAL CHEMOTHERAPY
INTRODUCTION
Topically applied chemotherapeutic drugs have a definite role in the treatment of epithelial disease, (Table 2) . In disciform keratitis acyclovir alone was of effect only in those patients who had never previously had topical steroids. Fourteen of 15 such patients responded satisfactorily, but if topical steroids had been used in a previous attack (with topical antivirals) then only one of 13 responded satisfactorily. The duration of treatment of acyclovir treated patients was shorter and rebound recurrences fewer than for those patients treated with a combination of acyclovir and steroids. In other words, once steroids were added to the regimen, all the familiar problems of steroid treatment, namely prolonged treatment therapy and frequent recurrences, were seen ( Collum and his colleagues' found that, in a comparison of acyclovir with or without topical steroids in the treatment of disciform keratitis, 40% of those patients treated with acyclovir alone healed within 50 days, but it is uncertain how many had had steroids previously, so that these results may have been improved if these patients had been excluded. Similarly Sanitato et al. '9 and Kaufman39 found that acyclovir alone had a beneficial effect in five of 12 patients with disciform keratitis, but it was not clear from their results how many of these patients had had prior attacks treated with steroids. Acyclovir has also been successfully used in the treatment of presumed herpetic iridoxcyclitis when given either topically (personal observation) or systemically. 4' It is suggested that for the first attack of herpes simplex induced stromal disease acyclovir or trifluoro- Table 3 Response of topical acyclovir (ACV) or triflurothymidine (F3T) on herpes simplex disciform keratitis in patients who either had never had topical steroids or had had a previous attack ofstromal disease treated with steroids and antivirals 
HERPES ZOSTER INFECTION
If a drug has an effect on the skin rash which is known to be due to direct viral invasion, then, if zoster keratouveitis in its many forms is due at least in part to viral invasion and virally induced tissue damage, it would be expected that that drug would control some of the corneal disease.
The earlier available antivirals had no effect on the acute stages of the rash, or the incidence of postherpetic neuralgia, when given either systemically as adenine arabinoside43 and cytosine arabinoside43 or topically as idoxuridine, which initially, when combined with dimethyl sulphoxide (DMSO) for skin penetration, was thought to be of benefit45 but later found to have no benefit over DMSO alone.,% Systemic steroids used to lessen postherpetic neuralgia resulting from viral induced tissue damage carried the risk of virol dissemination. 47 (Table 4 ). The total treatment duration in the acyclovir treated group was considerably less than for the steroid treated group. In a short follow-up of less than one year, while 12 of the 19 steroid treated patients had a recurrence of their keratouveitis once treatment was either being tapered off or stopped, none of the acyclovir treated patients had a recurrence. Corneal epithelial disease resolved significantly faster than in the acyclovir group, but there was no significant difference in the resolution of stromal disease, uveitis, or scleritis in the two groups.
In an attempt to gain a broader impression of the usefulness of acyclovir in acute herpes zoster keratouveitis, a retrospective analysis was carried out of all patients with this disease presenting at the Southampton Eye Hospital over a two-year period and treated by a number of doctors.'5 Retrospective analyses are not ideal, and exact differences between groups for particular signs resolving may not be clear, but, when the clinical outcome of these patients treated with either topical acyclovir or steroids or a combination of both was reviewed, a definite pattern emerged. Topical acyclovir alone controlled the disease process in 51 out of 56 patients. Those treated with acyclovir fared significantly better, with a quicker resolution of their keratouveitis, as there were no recurrences of the disease process in the first year after treatment had been stopped compared with a 50% incidence of those treated with topical steroids, many of whom are still on treatment, so that the total treatment duration of the steroid treated patients was much longer.-" With a longer follow-up two out of 56 of the patients treated with acyclovir had a recurrence of their keratouveitis, one of whom had had topical steroids for his lid involvement. 6 In an up-to-date retrospective analysis of all patients treated with topical acyclovir the time taken for resolution was the same for the different types of stromal disease (Table 5) . But acyclovir, when combined with steroids, showed no benefit compared with the steroids alone. In other words the addition of steroids produces all the problems of prolonged treatment and frequent recurrences.
These trials, however, may have merely been showing the deleterious effect of steroids and not a beneficial one of acyclovir, as it was ethically impossible to use placebo controls in patients who had established keratouveitis causing a painful inflamed simply an acute punctate keratopathy (Table 6) . Of the 20 patients treated 10 had topical acyclovir, 10 topical placebo. All patients treated with topical acyclovir fared well, with a quick resolution and no disease progression or stromal involvement. Eight out of 10 of the patients treated with placebo had a progression of their disease, with stromal involvement, and acyclovir had to be added before the disease resolved. In reviewing all 112 acyclovir treated patients, all but one of whom presented within three weeks of the onset of their disease, we noted nine not responding to acyclovir alone (Table 7) . It is suggested that if scleritis or uveitis persists, especially if synechiae have formed, steroids should not be withheld.
CONCLUSION
Most cases of herpes zoster stromal disease follow epithelial involvement, with nummular opacities occurring sooner than disciform keratitis, suggesting a different mechanism. As epithelial lesions are known to be associated with herpes zoster virus, and as stromal disease can be prevented if epithelial disease is treated with antiviral chemotherapy, and established stromal lesions can be similarly treated, this evidence suggests that viral replication has a major role in the development of these lesions.
Previously topical steroids were the only available treatment of herpes zoster keratouveitis, and they had to be continued for up to 18 months or more, with much disease progression, ocular damage and visual loss. With topical acyclovir there is a shorter treat-ment duration, less recurrence, and less disease spread, but it must be emphasised that this comparison may be showing up the deleterious effects of steroids on viral induced stromal disease, and further prophylactic oral and topically based clinical trials are required to determine the relative effective role of antivirals in this condition, particularly as the exact mechanism of the production of the different signs is not yet known. For instance, nummular opacities, which develop earlier than disciform keratitis and in direct relation to epithelial ulcers, may be due to a different immune mechanism than the cell mediated delayed immune mechanism of disciform keratitis.
General conclusion
In both herpes simplex and zoster ocular infections, stromal lesions usually follow after epithelial disease.
The exact mechanism of these disease processes is not yet fully understood, partly owing to the lack of any suitable animal model. But the fact that stromal disease occurs after epithelial disease, and the effect shown here of antivirals on stromal disease, suggest that viral replication has a major role in the production of the stromal lesions. Antiviral treatment alone without the use of steroids offers considerable advantages, but the exact role of antivirals in the disease process must await further laboratory work and coded clinical trials. Prophylactic placebo controlled trials are required to determine whether topical antivirals are superior to placebo in all aspects of stromal disease, and whether any significant vision threatening stromal scarring results from the withholding of steroids.
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